Our Solution

Clinical Solutions

The value of Optiscan technology in clinical practice (Prof. Mark Preul: Director of Neurosurgery Research at the Barrow Neurological Institute).

Current Practice

Conventional histopathology is used to microscopically examine the shape, size and pattern of cells and tissues to establish the presence or absence of disease, most notably cancer.

This approach dates back to the late 1600s when Anthony van Leeuwenhoek developed basic staining techniques and used a light microscope to examine cells. These same techniques were further developed in the mid 1800s to produce the standard hematoxylin and eosin stain routinely used in histopathology around the world.

More recently, the frozen section has largely remained unchanged since first described by pathologist Dr Louis B. Wilson in 1905 at the request of surgeon Dr William Mayo, one of the founders of the Mayo Clinic.

Today, with a growing and aging population demographic, the high global burden of cancer, and the significant pressures on healthcare systems globally, these processes are considered inefficient, technically deficient, unsustainable and outdated.

The Optiscan Solution

Optiscan technology offers many solutions over the well-recognised challenges of traditional histopathology:

Traditional Histopathology: Challenges Optiscan Technology: Solution
✖ Hours to days to receive results, generating delays in clinical decision making. ✔ Real-time, in vivo, non-destructive clinical feedback allowing immediate, informed decisions.
✖ Single point in time understanding of tissue status. ✔ Ability to monitor the same area point over time.
✖ Incomplete disease identification potential. ✔ Track treatment impact and potential disease effects.
✖ Pathologist and clinician separately located. Potential communication issues. ✔ Pathologist-clinician collaboration via digital workflow.
✖ Samples only a small fraction of possible diseased area. ✔ Unlimited microscopic sampling across diseased tissues.
✖ Single point in time understanding of tissue status. ✔ Greater economic efficiencies in healthcare systems.

Optiscan technology establishes a new standard of precision healthcare through earlier detection, diagnosis, and treatment of cancer.

Life Science and Research Solutions

Current Situation

Conventional microscopy allows the examination of very small objects that are beyond the resolution of the human eye, and has helped unravel the cellular mechanisms behind physiology and pathology.

However, traditional benchtop microscopes have many limitations in life sciences research:

  • You can only image a single slice of tissue at an instant in time
  • Tissue sample is dead
  • Image acquisition can be slow to obtain
  • They are numerous sources of processing artifacts introduced
  • You lose biological and system context by removing the sample from its natural state

The Optiscan Solution

Our technology offers the opportunity for researchers to visualise biological structures in their natural environment, to ascertain living biological mechanisms and their interactions in-vivo. Our technology enables users to repeatedly monitor the progress of disease processes or therapeutic treatment within living structures, on a consistent and continual basis, minimising the need to sacrifice animals to answer research questions.

The opportunity to see life connected with Optiscan technology presents new study possibilities for life sciences research, and the potential to generate high impact publications that actively elevates your research facility, and accelerates the pursuit and delivery of valuable drug discoveries and therapeutics in humans.